Entertain Hybrid Approaches and Comprehensive Views of Process Analytics, Automation, and Quality Assurance Whoever said there’s nothing new under the sun was not, evidently, referring to bioreactors.
Recent Survey Finds Commercial-Stage Use of Disposables Continuing on Upward Trajectory Bioreactors are constantly evolving, with improvements being introduced rapidly. To assess how the industry will ...
Rentschler Biotechnologie GmbH has announced the investment of €24m to build a Twin system with two 3,000 L stainless steel bioreactors mainly targeting market supply at the company’s site in Laupheim ...
WUXI, China & BETHLEHEM, Pa.--(BUSINESS WIRE)--WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, ...
We checked in with Kent Payne, Catalent VP/GM for development and clinical services, after hearing about the CDMO's plans for a bioprocessing plant reliant on single-use technology. The Madison, WI, ...
Laupheim, Germany, March 23, 2015 / B3C newswire / -- Rentschler Biotechnologie GmbH, a leading contract manufacturing and development organization (CDMO) for biopharmaceuticals, announced today that ...
Dublin, June 28, 2024 (GLOBE NEWSWIRE) -- The "Bioreactors Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Fabrication Material, Type of Bioprocess, Type of Biologic, and Key ...
LONDON--(BUSINESS WIRE)--The bioreactors market is expected to grow by USD 4.19 billion, accelerating at a CAGR of over 19% during the forecast period. Download Free Sample Report The rise in the ...
It takes a lot of infrastructure, and money, to build the giant bioreactors experts say are needed to mass produce raw materials to make things like medicine, vaccines and cultivated meat. Matt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results